Viewing Study NCT01596335


Ignite Creation Date: 2025-12-24 @ 10:10 PM
Ignite Modification Date: 2026-02-24 @ 2:09 PM
Study NCT ID: NCT01596335
Status: COMPLETED
Last Update Posted: 2018-10-25
First Post: 2012-05-09
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Clinical Study of TA-650 in Patients With Refractory Kawasaki Disease
Sponsor: Tanabe Pharma Corporation
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Kawasaki Disease Refractory to Initial Therapy With Intravenous Immunoglobulin View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Infliximab View
None REMICADE View
None TA-650 View
None intravenous immunoglobulin View
None Kawasaki disease View
None IVIG View